CVEvulnerability

CVE-2021-43935

9.8 CRITICAL Published 2021-12-15 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2021-12-15
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
8.1 HIGH — CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS 3.1 ([email protected])
9.8 CRITICAL — CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS 2.0 ([email protected])
6.8 MEDIUM — AV:N/AC:M/Au:N/C:P/I:P/A:P
Weaknesses
CWE-287, CWE-288

Description

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

Affected configurations

• baxter welch allyn connex cardio (>= 1.0.0 <= 1.1.1) • baxter welch allyn diagnostic cardiology suite 2.1.0 • baxter welch allyn rscribe resting ecg system (>= 5.01 <= 7.0.0) • baxter welch allyn vision express holter analysis system (>= 6.1.0 <= 6.4.0) • baxter welch allyn hscribe holter analysis system firmware (>= 5.01 <= 6.4.0) • baxter welch allyn q-stress cardiac stress testing system firmware (>= 6.0.0 <= 6.3.1) • baxter welch allyn xscribe cardiac stress testing system firmware (>= 5.01 <= 6.3.1)

Related

Weakness · CWE (2)

  • CWE-287 Improper Authentication weakness
  • CWE-288 Authentication Bypass Using an Alternate Path or Channel weakness

References